Aqr Capital Management LLC Ovid Therapeutics Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.31 - $4.04 $998,848 - $1.22 Million	-301,767 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $593,036 - $806,888	179,708 Added 147.23%	301,767 $1.18 Million
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $221,846 - $409,773	91,672 Added 301.68%	122,059 $491,000
Q4 2020 Feb 16, 2021	SELL	$2.28 - $6.84 $46,163 - $138,489	-20,247 Reduced 39.99%	30,387 $70,000
Q3 2020 Nov 16, 2020	BUY	$5.39 - $8.24 $272,917 - $417,224	50,634 New	50,634 $291,000

39.2M

10.3K

200

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $79.6M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.